Announcements Trials
Browse Landscape

Phase

Phase 2 31Phase 1 9Phase 3 7Phase 4 3Phase 2/3 2Phase 1/2 2

Status

Active not recruiting 3Terminated 2Recruiting 2Completed 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Cisplatin 111Carboplatin 111pembrolizumab 109Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × cabazitaxel × Clear all
NCT01505868 2021-07-30

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
170 enrolled 22 charts
Genitourinary

Lymphadenopathy, Prostatic Neoplasms

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Sanofi

Phase 1/2 Completed
39 enrolled 18 charts
Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡